Clinical Trial Update: Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety and immune response to two admixtures of a tetravalent dengue virus vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Tetravalent dengue virus vaccine (investigational, admixtures)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 1 | Status: COMPLETED